Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy

Por Doherty, Mark K, Morris, Patrick G
Publicado no Int J Womens Health (2015)

Monitoring and Management of Immune‐Related Adverse Events Associated With Programmed Cell Death Protein‐1 Axis Inhibitors in Lung Cancer

Por O'Kane, Grainne M., Labbé, Catherine, Doherty, Mark K., Young, Kelvin, Albaba, Hamzeh, Leighl, Natasha B.
Publicado no Oncologist (2016)

Long term responders to palliative chemotherapy for advanced biliary tract cancer

Por Doherty, Mark K., McNamara, Mairéad G., Aneja, Priya, McInerney, Emma, Moignard, Stephanie, Horgan, Anne M., Jiang, Haiyan, Panzarella, Tony, Jang, Raymond, Dhani, Neesha, Hedley, David, Knox, Jennifer J.
Publicado no J Gastrointest Oncol (2017)

Development and evaluation of screening dysphagia tools for observational studies and routine care in cancer patients

Por Borean, Michael, Shani, Kishan, Brown, M. Catherine, Chen, Judy, Liang, Mindy, Karkada, Joel, Kooner, Simranjit, Doherty, Mark K., O'Kane, Grainne M., Jang, Raymond, Elimova, Elena, Wong, Rebecca K., Darling, Gail E., Xu, Wei, Howell, Doris, Liu, Geoffrey
Publicado no Health Sci Rep (2018)

The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis

Por O'Kane, Grainne M., Su, Jie, Tse, Brandon C., Tam, Vivian, Tse, Tiffany, Lu, Lin, Borean, Michael, Tam, Emily, Labbé, Catherine, Naik, Hiten, Mittmann, Nicole, Doherty, Mark K., Bradbury, Penelope A., Leighl, Natasha B., Shepherd, Frances A., Richard, Nadine M., Edelstein, Kim, Shultz, David, Brown, M. Catherine, Xu, Wei, Howell, Doris, Liu, Geoffrey
Publicado no Oncologist (2019)